An observational controlled study on vaginal blood flow and sexual functioning after early stage cervical cancer treatment
- Conditions
- 10029903cancer of the cervixcervical cancer1003858810046828
- Registration Number
- NL-OMON42343
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 30
Pre-menopausal women who have undergone conventional radical hysterectomy with pelvic lymphadenectomy using the Okabayashi method (RHL-WO) at the AMC for the treatment of early stage cervical cancer (FIGO IA2 * IIA). Women are selected on pre-menopausal status because menopausal status can influence the vaginal bloodflow. Women with a history of cervical cancer can be included if treatment has been completed at least 12 months before. All eligible patients have been treated for FIGO stage IA2-IIA cervical cancer with therapyRHL-WO; have no signs of recurrent or metastatic cervical cancer after 1 year; have not received external beam radiation therapy, intravaginal brachytherapy and/or concomitant chemotherapy; did not have their ovaries removed during surgery; are capable of understanding, reading and writing the Dutch language; are not pregnant; have performance status of WHO 1-2, Karnofsky >60; and are <75 52 years of age. Use of medication and hormonal substitutes is registered.
Women that receive radiotherapy and/or concomitant chemotherapy; had their ovaries removed during surgery; or are pregnant; are not included.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method